Akebia Therapeutics
AKBA
#6958
Rank
A$0.61 B
Marketcap
$2.95
Share price
4.02%
Change (1 day)
105.96%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -A$62.07 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are A$0.17 Billion. In 2023 the company made an earning of -A$78.86 Million, an increase over its 2022 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$62.07 Million-21.29%
2023 -A$78.86 Million-45.12%
2022 -A$0.15 Billion-66.55%
2021 -A$0.43 Billion-26.24%
2020 -A$0.59 Billion33.94%
2019 -A$0.44 Billion66.52%
2018 -A$0.27 Billion123.53%
2017 -A$0.12 Billion-43.34%
2016 -A$0.21 Billion123.58%
2015 -A$92.21 Million63.95%
2014 -A$56.24 Million181.24%
2013 -A$20 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.10 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.33 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$27.93 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.27 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA